Source | Timepoint | Outcome | Description |
---|---|---|---|
Primary outcome measures | |||
 EMR | 6, 12 | Buprenorphine retention | Percentage of patients who initiated buprenorphine who have at least 6 and 12 months of continuous treatment with buprenorphine with no more than a 7-day lapse between prescriptions [51, 52] Number of days of longest continuous buprenorphine treatment with no breaks in care |
Source | Â | Outcome | Description |
---|---|---|---|
Secondary patient outcome measures | |||
 P INT SP INT | BL, 3, 12 BL, 3, 12 | Patient opioid use | Heroin, prescription opioid, and other opioid use in the past 30 days using questions from the National Survey on Drug Use and Health [57,58,59] |
 EMR | 6, 12 | Medication adherence | Percentage of patients with a buprenorphine prescription with a urine test positive for buprenorphine metabolites |
 EMR | 6, 12 | OUD treatment retention | Percentage of patients who initiated OBOT who had continued visits (no more than a 30-day lapse between visits) with any provider for a substance use disorder for 3, 6, and 12 months [8, 56] |
 P INT  SP INT | BL, 3, 12 BL, 3, 12 | Patient other substance use | |
 P INT | BL, 3, 12 | Overdose risk | Opioid Overdose Risk Assessment scale [60] |
 P INT | BL, 3, 12 | Patient Substance use problems | Substance-related problems in the past 30 days using the Short Inventory of Problems |
 P INT | BL, 3, 12 | Patient health | Physical health in the past 30 days; depression and anxiety |
 P INT | BL, 3, 12 | Quality of life | Functional impairment in work/school, family, and social life using the 5-item Sheehan Disability Scale [61] |
 P INT | BL, 3, 12 | Communication | Adapted from the FACES IV [62] |
 P INT | BL, 3, 12 | Employment status | Full-time, part-time, unemployed, other (e.g., students, persons keeping house or caring for children full time, retired or disabled persons) [63] |
 EMR  P INT | 6, 12 BL, 3, 12 | Healthcare utilization | Number of outpatient medical and behavioral health visits over the 12-month period |
 P INT | 3, 12 | Treatment satisfaction | Client Satisfaction Questionnaire (CSQ-8) [64] |
Secondary SP outcome measures | |||
 SP INT | BL, 3, 12 | Health | Physical health in the past 30 days; depression and anxiety |
 SP INT | BL, 3, 12 | Substance use | |
 SP INT | BL, 3, 12 | Quality of life | Functional impairment in work/school, family, and social life using the 5-item Sheehan Disability Scale [61] |
 SP INT | BL, 3, 12 | Communication | Adapted from the FACES IV [62] |
 SP INT | 3 | INSPIRE satisfaction | Client Satisfaction Questionnaire (CSQ-8) adapted to INSPIRE [64] |